Clinical trial · Observational
A Registry Study on HIV-related Lymphoma
Characteristics, Treatment and Outcomes of HIV-infected Patients With Malignant Lymphoma: A Registry Study of the European Hematology Association (EHA) Lymphoma Group
NCT05231135CI-TRIAL-00065389recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| AIDS Related Lymphoma | AIDS-Related Lymphoma | ONTOLOGY_EXACT | 0.98 |
| HIV Related Lymphoma | Lymphoma | PROBABILISTIC | 0.70 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- 2-year overall survival (OS)
- timeFrame
- 2 years
- description
- OS measured from the date of diagnosis to last follow-up or to death from any cause.
- measure
- 2-year progression-free survival (PFS)
- timeFrame
- 2 years
- description
- PFS calculated from the date of diagnosis to the time of progression, relapse, or death.
Secondary outcomes (4)
- measure
- Incidence of relapse (IR)
- timeFrame
- 5 years
- description
- Based on establised response criteria, e.g. Chesson et al. JCO 2014
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histology or cytology proven non-Hodgkin lymphoma or Hodgkin lymphoma * HIV-infection at time of lymphoma diagnosis * Lymphoma diagnosis since 01.01.2010 * Adult patients ≥ 18 years * Written informed consent Exclusion Criteria: * HIV-diagnosis \> 3 months after the diagnosis of malignant lymphoma * Non-Compliance or lack of opportunity for follow-up (for the prospective part of the study)
References
Publications (0)
Data not yet available
No reference posted for this study.